scholarly article | Q13442814 |
P50 | author | Christopher H. Contag | Q55099930 |
Robert S. Negrin | Q110528996 | ||
P2093 | author name string | Andreas Beilhack | |
Jeanette Baker | |||
Stephan Schulz | |||
Vu H Nguyen | |||
Robert Zeiser | |||
Martin Buess | |||
P2860 | cites work | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
Determination of lymphocyte division by flow cytometry | Q28253058 | ||
A function for interleukin 2 in Foxp3-expressing regulatory T cells | Q28590646 | ||
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia | Q33629928 | ||
Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). | Q34386649 | ||
Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity | Q34505678 | ||
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. | Q34515741 | ||
Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. | Q34516841 | ||
Interleukin 2 signaling is required for CD4(+) regulatory T cell function | Q34527240 | ||
Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling | Q34561791 | ||
CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 | ||
Shifting foci of hematopoiesis during reconstitution from single stem cells | Q35122188 | ||
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets | Q35847952 | ||
Tolerance, not immunity, crucially depends on IL-2. | Q35877199 | ||
Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. | Q36369780 | ||
Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization | Q36402763 | ||
Identification of the Immunophilins Capable of Mediating Inhibition of Signal Transduction by Cyclosporin A and FK506: Roles of Calcineurin Binding and Cellular Location | Q36694583 | ||
Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells | Q38323893 | ||
Early IL-2 Production by Mouse Dendritic Cells Is the Result of Microbial-Induced Priming | Q40649514 | ||
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response | Q40651436 | ||
Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells | Q41743877 | ||
Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. | Q43829312 | ||
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor | Q43873032 | ||
Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells | Q44072016 | ||
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging | Q44189640 | ||
New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. | Q44200460 | ||
The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade | Q44217780 | ||
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 | ||
Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery | Q44741787 | ||
Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model | Q45251857 | ||
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. | Q45299244 | ||
Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells | Q46739924 | ||
Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function | Q47579310 | ||
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. | Q54073234 | ||
Activation requirements for the induction of CD4+CD25+ T cell suppressor function | Q56903555 | ||
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma | Q56904280 | ||
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance | Q57202280 | ||
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors | Q70055061 | ||
In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A | Q71029782 | ||
Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome | Q72574737 | ||
Combination therapy with a CD4-CDR3 peptide analog and cyclosporin A to prevent graft-vs-host disease in a MHC-haploidentical bone marrow transplantation model | Q74063423 | ||
Mycophenolate mofetil impairs the maturation and function of murine dendritic cells | Q74183071 | ||
Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction | Q74191513 | ||
CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 | Q74660381 | ||
Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes | Q77758613 | ||
The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality | Q78033315 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 390-399 | |
P577 | publication date | 2006-03-07 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production | |
P478 | volume | 108 |